Human Microbiome Market is estimated to be US$ 3657.31 million by 2030 with a CAGR of 19.8% during the forecast period

 


Human Microbiome Market accounted for US$ 590.39 million in 2020 and is estimated to be US$ 3657.31 million by 2030 and is anticipated to register a CAGR of 19.8%. Human tissue is covered with trillions of microorganisms, these microorganisms include bacteria, fungi, and viruses which are known as the microbiome. They contribute 2-3Kg weight inside the human body in the abundance of human microbes. Technological advancement and analytical techniques increase the microbiome. Human microbiome is an aggregate of all microbiota that resides within human tissues and biofluids with corresponding anatomical sites, including the mammary glands, skin, uterus, seminal fluid, lung, saliva, ovarian follicles, conjunctiva, oral mucosa, and gastrointestinal tract. 

The report "  Human Microbiome Market, By Product (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Other Diseases), By Disease (Probiotics, Prebiotics, Synbiotic, and Other Products), By Application (Therapeutic and Diagnostic), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

 

Key Highlights:

·         On 23 September 2021, PhenoBiome launched the first human gut microbiome assay through Genetic Direction, which is Dallas-based distributor of genetics-based health management programs, and also Clinical Enterprise, Inc., a Eurofins Scientific company, will process the assays in its CLIA- and CAP-certified laboratory. 

·         On 12 October 2021, Consumer Dermatology Company announces, DERMALA, Additions to a Successful Acne Product Range pretended for treatment of acne powered by the human microbiome extends its products, and also line up with the addition of six new products. The line extension combines SUPPLEMENT to Be Daily Pre Probiotic Skin Mix, Best CLEANSE Forever Hydrating Cleanser for Sensitive/Normal Skin, SUPPLEMENT to Be Daily Vitamin Skin Mix.

·          4D pharma merged with Longevity Acquisition Corporation to earn a NASDAQ listing in 2020. In accomplishment, Longevity will support and accelerate the ongoing development of 4D pharma’s Live Biotherapeutic, it is a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, which helps to cure disease

·         In 2020, BiomX collaborated with Boehringer Ingelheim to utilize the microbiome-based biomarker discovery platform to probably identify biomarkers associated with patient phenotypes in Inflammatory Bowel Disease (IBD).

 

Analyst View:

Rising focus on human micro biome therapeutics development -Human gut microbiomes play a role in improving the efficacy of therapeutic compounds, study shows the right combination of microbes in the human body is beneficial for treating different conditions, the association among microbes and specific disease states can generate opportunities for drug developers or vaccine manufacturers. Many small innovative players are operating in the market there are various high-growth opportunities for stakeholders to buy out companies to study microbiomes in the hopes to identify new drugs and drug targets for indication, like liver disorders, obesity, diabetes, and metabolic disorders. The human body is a diverse community of symbolic, pathogenic microorganisms, and commensal, collectively known as microbiota. In that only 30-40 species as the bulk of microbiota is shared among individuals, analyzing specific bacteria from trillions of species is a highly challenging task.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3787

Key Market Insights from the report:

Global Human Microbiome Market accounted for US$ 590.39 million in 2020 and is estimated to be US$ 3657.31 million by 2030 and is anticipated to register a CAGR of 19.8%.  The Global Human Microbiome Market is segmented by Product, Disease, Application, and Region.

·         By Product, Global Human Microbiome Market is segmented into Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Other Diseases.

·         By Disease, Global Human Microbiome Market is segmented into Probiotics, Prebiotics, Synbiotic, and Other Products.

·         By Application, Global Human Microbiome Market is segmented into Therapeutic and Diagnostic.

·         By Region, Global Human Microbiome Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

 

Competitive Landscape:

The key players operating the global human microbiome market involves Enterome Bioscience, Yakult, Dow DuPont Inc., Seres Therapeutics, ViThera Pharmaceuticals, Second Genome Inc., MatriSys Bioscience, Caelus Health, Rebiotix Inc., Assembly Biosciences Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

 

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

 

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Food Allergy Market is estimated to be US$ 7.0 Bn by 2030 with a CAGR of 7.9% during the forecast period

Image
  The Food Allergy Market accounted for US$ 3.3 Bn in 2020 and is estimated to be US$ 7.0 Bn by 2030 and is anticipated to register a CAGR of 7.9%. Food allergy market is driven by various factors such as globalization of food trade, growth in incidences of allergic disorders among consumers. Food allergy is an abnormal response cause by various different food products such as milk, soy, wheat, peanuts and various products which are present in the market. Food allergy hampers the immune response of the body, as sometimes body is not able to fight with certain microbes which enter our body through various food products and therefore leading to food allergic responses.   The report " Food Allergy Market, By Technology (Biosensor-Based, Immunoassay-Based, ELISA PCR Based and Other Technologies), By  Source (Milk, Egg,  Soy, Tree Nuts, Peanuts, Wheat, Seafood and Others), By Diagnosis (Primary and Secondary), By Treatment (Anti Histamines and Adrenaline), By End – Us...
Read more

Infusion Pumps Market is estimated to be US$ 24.63 billion by 2030 with a CAGR of 9.90% during the forecast period

Image
  The Infusion Pumps Market accounted for US$ 12.34 billion in 2020 and is estimated to be US$ 24.63 billion by 2030 and is anticipated to register a CAGR of 9.90%..  An infusion pump infuses fluids, medication or nutrients into a patient's cardiovascular system. It’s generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used. Infusion pumps can administer fluids in ways in which would be impractically expensive or unreliable if performed manually by nursing staff. for instance , they will administer as little as 0.1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient, up to maximum number per hour (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.  Because they will also produce quite high but controlled pressures, they will inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally ...
Read more

Poultry Vaccines Market is estimated to be US$ 3.47 billion by 2030 with a CAGR of 5.8% during the forecast period

Image
  The Poultry Vaccines Market accounted for US$ 1.98 billion in 2020 and is estimated to be US$ 3.47 billion by 2030 and is anticipated to register a CAGR of 5.8%. Vaccination is an important aspect of the chicken flock's health management. Vaccinating birds against a variety of diseases prevents the spread of disease. A vaccine helps to avoid a disease by inducing or enhancing the production of antibodies in the bird's immune system, which then fight the invading causative organisms. Chicken vaccines play a crucial part in keeping poultry flocks healthy. Vaccinating the chicken flock helps to prevent a variety of diseases. Vaccines create antibodies that aid the body of the bird in fighting off invading pathogens. The report " Poultry Vaccines Market, By Type (Live Vaccines and Killed Vaccines), By Application (Chicken and Duck & Goose), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast ...
Read more